X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (10) 10
male (10) 10
index medicus (9) 9
middle aged (9) 9
aged (8) 8
prostate cancer (8) 8
computer graphics (7) 7
treatment outcome (7) 7
computer science (6) 6
prostatic neoplasms - pathology (6) 6
artificial intelligence (5) 5
cancer (5) 5
image processing and computer vision (5) 5
oncology (5) 5
analysis (4) 4
computers (4) 4
medical prognosis (4) 4
metastasis (4) 4
neoplasm staging (4) 4
aged, 80 and over (3) 3
animación por ordenador (3) 3
animation par ordinateur (3) 3
animation, computer (3) 3
antineoplastic agents - therapeutic use (3) 3
antineoplastic combined chemotherapy protocols - adverse effects (3) 3
antineoplastic combined chemotherapy protocols - therapeutic use (3) 3
bladder cancer (3) 3
clinical trials (3) 3
computer animation (3) 3
computer science, general (3) 3
computer-assisted filmmaking (3) 3
computer-generated animation (3) 3
computeranimation (3) 3
disease-free survival (3) 3
docetaxel (3) 3
drug administration schedule (3) 3
female (3) 3
image processing (3) 3
kaplan-meier estimate (3) 3
mitoxantrone (3) 3
orchiectomy (3) 3
prednisone (3) 3
prostate (3) 3
prostate-specific antigen (3) 3
prostatic neoplasms - drug therapy (3) 3
survival analysis (3) 3
technique (3) 3
tumors (3) 3
urinary bladder neoplasms - surgery (3) 3
urology & nephrology (3) 3
use of (3) 3
abridged index medicus (2) 2
androgen antagonists - therapeutic use (2) 2
androgens (2) 2
animation techniques (2) 2
bildbehandling (2) 2
bone (2) 2
cancer therapies (2) 2
chemotherapy (2) 2
clinical-trials (2) 2
computer science, software engineering (2) 2
computer simulation (2) 2
computer vision (2) 2
computergraphik (2) 2
cyberspace (2) 2
cystectomy - adverse effects (2) 2
datorgrafik (2) 2
datorkonst (2) 2
design (2) 2
disease progression (2) 2
estramustine (2) 2
gemcitabine (2) 2
gonadotropin-releasing hormone - antagonists & inhibitors (2) 2
graphics (2) 2
gráficos por ordenador (2) 2
hematology, oncology and palliative medicine (2) 2
infographie (2) 2
interaction homme-ordinateur (2) 2
medical research (2) 2
medicine, general & internal (2) 2
metastases (2) 2
neoplasm grading (2) 2
neoplasm metastasis (2) 2
nonsteroidal anti-inflammatory drugs (2) 2
pathology (2) 2
patients (2) 2
progression (2) 2
proportional hazards models (2) 2
prostatectomy (2) 2
prostatic neoplasms - radiotherapy (2) 2
prostatic neoplasms - surgery (2) 2
radiation (2) 2
radical prostatectomy (2) 2
radiotherapy (2) 2
realidad virtual (2) 2
réalité virtuelle (2) 2
simulations (2) 2
survival (2) 2
survival rate (2) 2
taxoids - administration & dosage (2) 2
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Robarts - Stacks (4) 4
UTL at Downsview - May be requested (4) 4
Gerstein Science - Stacks (2) 2
Earth Sciences (Noranda) - Stacks (1) 1
Engineering & Comp. Sci. - Stacks (1) 1
Royal Ontario Museum - Stacks (1) 1
UofT at Mississauga - Stacks (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2016, Volume 387, Issue 10024, pp. 1163 - 1177
Journal Article
Lancet Oncology, ISSN 1470-2045, 2015, Volume 16, Issue 1, pp. 76 - 86
Summary Background Patients with muscle-invasive urothelial carcinoma of the bladder have poor survival after cystectomy. The EORTC 30994 trial aimed to... 
Hematology, Oncology and Palliative Medicine | ADJUVANT CHEMOTHERAPY | PLUS CISPLATIN | METAANALYSIS | NEOADJUVANT CHEMOTHERAPY | ONCOLOGY | DOXORUBICIN | METHOTREXATE | VINBLASTINE | CANCER | GEMCITABINE | Lymph Node Excision | Cystectomy - mortality | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Carcinoma - mortality | Male | Vinblastine - administration & dosage | Cystectomy - adverse effects | Urothelium - pathology | Cisplatin - administration & dosage | Time Factors | Urinary Bladder Neoplasms - pathology | Female | Chemotherapy, Adjuvant | Carcinoma - pathology | Doxorubicin - administration & dosage | Carcinoma - drug therapy | Urinary Bladder Neoplasms - mortality | Drug Administration Schedule | Time-to-Treatment | Carcinoma - surgery | Deoxycytidine - administration & dosage | Europe | Kaplan-Meier Estimate | Proportional Hazards Models | Treatment Outcome | Urinary Bladder Neoplasms - drug therapy | Urinary Bladder Neoplasms - surgery | Canada | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Intention to Treat Analysis | Methotrexate - administration & dosage | Urothelium - surgery | Neoplasm Staging | Urothelium - drug effects | Deoxycytidine - analogs & derivatives | Care and treatment | Chemotherapy | Carcinoma | Hospitals | Cancer
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2012, Volume 13, Issue 5, pp. 549 - 558
Journal Article
The Lancet, ISSN 0140-6736, 12/2018, Volume 392, Issue 10162, pp. 2353 - 2366
Journal Article
The Visual Computer, ISSN 0178-2789, 4/2004, Volume 20, Issue 1, pp. 1 - 3
Journal Article
BJU International, ISSN 1464-4096, 11/2017, Volume 120, Issue 5B, pp. E45 - E51
Journal Article
American Journal of Pathology, The, ISSN 0002-9440, 2007, Volume 170, Issue 1, pp. 160 - 175
Journal Article
Journal Article